Evidence brief · Supplement

Kratom (Mitragyna speciosa) for Pain / opioid withdrawal

Evidence grade D — Observational only

Overall grade
Grade D
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade D — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Pain / opioid withdrawalEvidence grade D

    Observational only

    Unclearlow

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Pain / opioid withdrawal (grade D).

The evidence in words

The verdict

For pain / opioid withdrawal, Kratom (Mitragyna speciosa) earns evidence grade D (unclear effect, low consistency) — the evidence does not support the claim. Observational only

How it might work

Its alkaloids are partial agonists at mu-opioid receptors (with less respiratory depression than classical opioids) plus adrenergic effects at low doses.

How to use it

Safety & cautions

Dependence and withdrawal occur; risks rise with high doses, other depressants (alcohol, benzodiazepines) and adulterated products. Liver-injury case reports exist. Legality varies by region.

Bottom line

Pharmacologically real but genuinely risky and habit-forming — not a casual supplement. If used to manage opioid problems, that belongs in a clinical setting, not self-treatment.

Goes with

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.